Is it true that ozone is always toxic? The end of a dogma

Toxicology and Applied Pharmacology

Volumn 216, Issue 3, 2006, Pages 493-504

  Bocci, Velio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

4 Hydroxynonenal; Acute oxidative stress; Antioxidants; Lungs; Ozone; Ozonetherapy

Indexed keywords

OZONE;

ARTICLE; CHEMISTRY; DOSE CALCULATION; EXPOSURE; HUMAN; NONHUMAN; OXIDATIVE STRESS; OZONE THERAPY; PHYSICIAN; PRESCRIPTION; RESPIRATORY SYSTEM; SKIN; TOPOGRAPHY; TOXICITY; TROPOSPHERE;

AIR POLLUTANTS; ANIMALS; FATTY ACIDS, UNSATURATED; HUMANS; OXIDANTS, PHOTOCHEMICAL; OXIDATION-REDUCTION; OZONE; RESPIRATORY TRACT DISEASES;

EID: 33750062921     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.06.009     Document Type: Article

References (171)

1. Alary J., Geuraud F., and Cravedi J.P. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol. Aspects Med. 24 (2003) 177-187
2. Andreula C.F., Simonetti L., De Santis F., Agati R., Ricci R., and Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. AJNR. Am. J. Neuroradiol. 24 (2003) 996-1000
3. Antonicelli F., Parmentier M., Drost E.M., Hirani N., Rahman I., Donaldson K., and MacNee W. Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells. Free Radical Biol. Med. 32 (2002) 492-502
4. Aris R.M., Christian D., Hearne P.Q., Kerr K., Finkbeiner W.E., and Balmes J.R. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 148 (1993) 1363-1372
5. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J. Intern. Med. 251 (2002) 372-392
6. Awasthi Y.C., Ansari G.A., and Awasthi S. Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. Methods Enzymol. 401 (2005) 379-407
7. Ballinger C.A., Cueto R., Squadrito G., Coffin J.F., Velsor L.W., Pryor W.A., and Postlethwait E.M. Antioxidant-mediated augmentation of ozone-induced membrane oxidation. Free Radical Biol. Med. 38 (2005) 515-526
8. Barrera G., Pizzimenti S., and Dianzani M.U. 4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radical Biol. Med. 37 (2004) 597-606
9. Barber E., Menendez S., Leon O.S., Barber M.O., Merino N., Calunga J.L., Cruz E., and Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischemia. Mediat. Inflamm. 8 (1999) 37-41
10. Bates D.V. Ambient ozone and mortality. Epidemiology 16 (2005) 427-429
11. Baysan A., and Lynch E. Clinical management of root caries using ozone. In: Lynch E. (Ed). Ozone: the Revolution in Dentistry (2004), Quintessence Publ., Copenhagen 173-180
12. Beardsley S. Avoiding another Vioxx. Sci. Am. 292 (2005) 9-10
13. Bell M.L., Dominici F., and Samet J.M. A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study. Epidemiology 16 (2005) 436-445
14. Bell M.L., McDermott A., Zeger S.L., Samet J.M., and Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987-2000. JAMA 292 (2004) 2372-2378
15. Bette M., Nusing R.M., Mutters R., Zamora Z.B., Menendez S., and Schulz S. Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum. Shock 25 (2006) 23-29
16. Bhalla D.K., and Gupta S.K. Lung injury, inflammation, and inflammatory stimuli in rats exposed to ozone. J. Toxicol. Environ. Health, A 59 (2000) 211-228
17. Bocci V. Pharmacokinetic studies of interferons. Pharmacol. Ther. 13 (1981) 421-440
18. Bocci V. Metabolism of protein anticancer agents. (Updated and reprinted in 1994 in Int. Encyclopedia of Pharmacology and Therapeutics, Sec. 140 Anticancer Drugs, Oxford: Pergamon Press, pp. 387-436). Pharmacol. Ther. 34 (1987) 1-49
19. Bocci V. Interleukins. Clinical pharmacokinetics and practical implications. Clin. Pharmacokinet. 21 (1991) 274-284
20. Bocci V. Physicochemical and biologic properties of interferons and their potential uses in drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 9 (1992) 91-133
21. Bocci V. Does ozone therapy normalize the cellular redox balance?. Med. Hypotheses 46 (1996) 150-154
22. Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J. Biol. Regul. Homeostatic Agents 10 (1996) 31-53
23. Bocci V. Biological and clinical effects of ozone. Has ozonetherapy a future in medicine?. Br. J. Biomed. Sci. 56 (1999) 270-279
24. Bocci V. Oxygen-ozone Therapy. A Critical Evaluation (2002), Kluwer Academic Publishers, Dordrecht, The NT
25. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediat. Inflamm. 13 (2004) 3-11
26. Bocci V. Ozone. A New Medical Drug (2005), Springer, Dordrecht, The NT
27. Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch. Med. Res. 37 (2006) 425-435
28. Bocci V., and Aldinucci C. The use of hydrogen peroxide as a medical drug. Riv. Ital. Ossigeno-Ozonoter. 4 (2005) 30-39
29. Bocci V., and Paulesu L. Studies on the biological effects of ozone. 1. Induction of interferon gamma on human leucocytes. Haematologica 75 (1990) 510-515
30. Bocci V., Pacini A., Pessina G.P., Maioli E., and Naldini A. Studies on tumor necrosis factor (TNF)-I. Pharmacokinetics of human recombinant TNF in rabbits and monkeys after intravenous administration. Gen. Pharmacol. 18 (1987) 343-346
31. Bocci V., Luzzi E., Corradeschi F., Paulesu L., and Di Stefano A. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 12 (1993) 121-126
32. Bocci V., Luzzi E., Corradeschi F., Paulesu L., Rossi R., Cardaioli E., and Di Simplicio P. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J. Biol. Regul. Homeostatic Agents 7 (1993) 133-138
33. Bocci V., Valacchi G., Corradeschi F., Aldinucci C., Silvestri S., Paccagnini E., and Gerli R. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J. Biol. Regul. Homeostatic Agents 12 (1998) 67-75
34. Bocci V., Valacchi G., Corradeschi F., and Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediat. Inflamm. 7 (1998) 313-317
35. Bocci V., Valacchi G., Rossi R., Giustarini D., Paccagnini E., Pucci A.M., and Di Simplicio P. Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 10 (1999) 110-116
36. Bocci V., Borrelli E., Valacchi G., and Luzzi E. Quasi-total-body exposure to an oxygen-ozone mixture in a sauna cabin. Eur. J. Appl. Physiol. Occup. Physiol. 80 (1999) 549-554
37. Bocci V., Borrelli E., Corradeschi F., and Valacchi G. Systemic effects after colorectal insufflation of oxygen-ozone in rabbits. Int. J. Med. Biol. Environ. 28 (2000) 109-113
38. Bocci V., Larini A., and Micheli V. Restoration of normoxia by ozone therapy may control neoplastic growth: a review and a working hypothesis. J. Altern. Complement. Med. 11 (2005) 257-265
39. Broeckaert F., Arsalane K., Hermans C., Bergamaschi E., Brustolin A., Mutti A., and Bernard A. Lung epithelial damage at low concentrations of ambient ozone. Lancet 353 (1999) 900-901
40. Brouard S., Otterbein L.E., Anrather J., Tobiasch E., Bach F.H., Choi A.M., and Soares M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192 (2000) 1015-1026
41. Calabrese E.J. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ. Pollut. 138 (2005) 379-411
42. Candelario-Jalil E., Mohammed-Al-Dalain S., Leon O.S., Menéndez S., Pérez-Davidson G., and Merino N. Oxidative preconditioning affords against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J. Appl. Toxicol. 21 4 (2001) 297-301
43. Cheng J.Z., Sharma R., Yang Y., Singhal S.S., Sharma A., Saini M.K., Singh S.V., Zimniak P., Awasthi S., and Awasthi Y.C. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J. Biol. Chem. 276 (2001) 41213-41223
44. Chiarpotto E., Castello L., Leonarduzzi G., Biasi A., and Poli G. Role of 4-hydroxy-2,3-nonenal in the pathogenesis of fibrosis. BioFactors 24 (2005) 229-236
45. Cho H.Y., Zhang L.Y., and Kleeberger S.R. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am. J. Physiol.: Lung Cell. Mol. Physiol. 280 (2001) L537-L546
46. Christian D.L., Chen L.L., Scannell C.H., Ferrando R.E., Welch B.S., and Balmes J.R. Ozone-induced inflammation is attenuated with multiday exposure. Am. J. Respir. Crit. Care Med. 158 (1998) 532-537
47. Choudhary S., Zhang W., Zhou F., Campbell G.A., Chan L.L., Thompson E.B., and Ansari N.H. Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radical Biol. Med. 32 (2002) 360-369
48. Clavo B., Perez J.L., Lopez L., Suarez G., Lloret M., Rodriguez V., Macias D., Santana M., Morera J., Fiuza D., Robaina F., and Gunderoth M. Effect of ozone therapy on muscle oxygenation. J. Altern. Complement. Med. 9 (2003) 1-256
49. Corradi M., Alinovi R., Goldoni M., Vettori M., Folesani G., Mozzoni P., Cavazzini S., Bergamaschi E., Rossi L., and Mutti A. Biomarkers of oxidative stress after controlled human exposure to ozone. Toxicol. Lett. 134 (2002) 219-225
50. Cotovio J., Onno L., Justine P., Lamure S., and Catroux P. Generation of oxidative stress in human cutaneous models following in vitro ozone exposure. Toxicol. In Vitro 15 (2001) 357-362
51. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Ann. Rev. Physiol. 48 (1986) 721-731
52. Cross C.E. The antioxidant milieu at asthmatic respiratory tract surfaces. Pediatr. Res. 53 (2003) 365-368
53. Cross C.E., Reznick A.Z., Packer L., Davis P.A., Suzuki Y.J., and Halliwell B. Oxidative damage to human plasma proteins by ozone. Free Radical Res. Commun. 15 (1992) 347-352
54. Davis W.B., and Pacht E.R. Extracellular antioxidant defenses. In: Crystal R.G., et al. (Ed). The Lung. Scientific Foundation. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia 2271-2278
55. De Monte A., van der Zee H., and Bocci V. Major ozonated auto-haemotherapy in chronic limb ischemia with ulcerations. J. Complement. Altern. Med. 11 (2005) 363-367
56. Devlin R.B., McDonnell W.F., Mann R., Becker S., House D.E., Schreinemachers D., and Koren H.S. Exposure of humans to ambient levels of ozone for 6.6. hours causes cellular and biochemical changes in the lung. Am. J. Respir. Cell Mol. Biol. 4 (1991) 72-81
57. Dianzani M.U. 4-hydroxynonenal and cell signalling. Free Radical Res. 28 (1998) 553-560
58. Dianzani M.U. 4-Hydroxynonenal from pathology to physiology. Mol. Aspects Med. 24 (2003) 263-272
59. Di Paolo N., Bocci V., Cappelletti F., Petrini G., and Gaggiotti E. Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO). Int. J. Artif. Organs 25 (2002) 1194-1198
60. Di Paolo N., Bocci V., Salvo D.P., Palasciano G., Biagioli M., Meini S., Galli F., Ciari I., Maccari F., Cappelletti F., Di Paolo M., and Gaggiotti E. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. Int. J. Artif. Organs 28 (2005) 1039-1050
61. Di Simplicio P., Cacace M.G., Lusini L., Giannerini F., Giustarini D., and Rossi R. Role of protein-SH groups in redox homeostasis-the erythrocyte as a model system. Arch. Biochem. Biophys. 355 (1998) 145-152
62. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton W.R., Lee M.E., Nabel G.J., and Nabel E.G. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7 (2001) 693-698
63. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11 (1991) 81-128
64. Fakhrzadeh L., Laskin J.D., and Laskin D.L. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am. J. Respir. Cell Mol. Biol. 26 (2002) 413-419
65. Forman H.J., and Dickinson D.A. Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule. Free Radical Biol. Med. 37 (2004) 594-596
66. Forman H.J., Dickinson D.A., and Iles K.E. HNE-signaling pathways leading to its elimination. Mol. Aspects Med. 24 (2003) 189-194
67. Foucaud L., Bennasroune A., Klestadt D., Laval-Gilly P., and Falla J. Oxidative stress induction by short time exposure to ozone on THP-1 cells. Toxicol. In Vitro 20 (2006) 101-108
68. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
69. Goodman S.N. The methodologic ozone effect. Epidemiology 16 (2005) 430-435
70. Goldman M. Cancer risk of low-level exposure. Science 271 (1996) 1821-1822
71. Goldstein B.D., and Balchum O.J. Effect of ozone on lipid peroxidation in the red blood cell. Proc. Soc. Exp. Biol. Med. 126 (1967) 356-359
72. Gohil K., Cross C.E., and Last J.A. Ozone-induced disruptions of lung transcriptomes. Biochem. Biophys. Res. Commun. 305 (2003) 719-728
73. Halliwell B. Free radicals and antioxidants: a personal view. Nutr. Rev. 52 (1994) 253-265
74. Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr. 16 (1996) 33-50
75. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radical Res. 31 (1999) 261-272
76. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem?. FEBS Lett. 540 (2003) 3-6
77. Hamilton Jr. R.F., Eschenbacher W.L., Szweda L., and Holian A. Potential involvement of 4-hydroxynonenal in the response of human lung cells to ozone. Am. J. Physiol. 274 (1998) L8-L16
78. Hawgood S. Surfactant: composition, structure and metabolism. In: Crystal R.G., et al. (Ed). The Lung. Scientific Foundation. 2nd ed (1997), Lippincott-Raven Publishers, Philadelphia 557-571
79. Herbst U., Toborek M., Kaiser S., Mattson M.P., and Hennig B. 4-hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J. Cell. Physiol. 181 (1999) 295-303
80. Iles K.E., Dickinson D.A., Wigley A.F., Welty N.E., Blank V., and Forman H.J. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radical Biol. Med. 39 (2005) 355-364
81. Ito K., De Leon S.F., and Lippmann M. Associations between ozone and daily mortality: analysis and meta-analysis. Epidemiology 16 (2005) 446-457
82. Jacobs M.-Th. Untersuchung uber Zwischenfalle und typische komplikationen in der Ozon-sauerstoff-therapie. OzoNachrichten (1982) 5-11
83. Jalil E.C., Al-Dalain S.M., Leon-Fernandez O.S., Menendez S., Perez-Davison G., Merino N., Dam S., and Ajamieh H.H. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J. Appl. Toxicol. 21 (2001) 297-301
84. Janic B., Umstead T., Phelps D.S., and Floros J. Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation. Am. J. Physiol.: Lung Cell. Mol. Physiol. 288 (2005) L317-L325
85. Jardines D., Correa T., Ledea O., Zamora Z., Rosado A., and Molerio J. Gas chromatography-mass spectrometry profile of urinary organic acids of Wistar rats orally treated with ozonized unsaturated triglycerides and ozonized sunflower oil. J. Chromatogr., B 783 (2003) 517-525
86. Johnson N., Holmes J., and Lynch E. The implications of using ozone in general dental practice. In: Lynch E. (Ed). Ozone: the Revolution in Dentistry (2004), Quintessence Publ., Copenhagen 67-72
87. Keinan E., Alt A., Amir G., Bentur L., Bibi H., and Shoseyov D. Natural ozone scavenger prevents asthma in sensitized rats. Bioorg. Med. Chem. 13 (2005) 557-562
88. Kelly F.J., Mudway I., Krishna M.T., and Holgate S.T. The free radical basis of air pollution: focus on ozone. Respir. Med. 89 (1995) 647-656
89. Krishna M.T., Madden J., Teran L.M., Biscione G.L., Lau L.C., Withers N.J., Sandstrom T., Mudway I., Kelly F.J., Walls A., Frew A.J., and Holgate S.T. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur. Respir. J. 11 (1998) 1294-1300
90. Larini A., Bianchi L., and Bocci V. The ozone tolerance: I) Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat cells. Free Radical Res. 37 (2003) 1163-1168
91. Larini A., Bianchi L., and Bocci V. Effect of 4-hydroxynonenal on antioxidant capacity and apoptosis induction in Jurkat T cells. Free Radical Res. 38 (2004) 509-516
92. Last J.A., Gohil K., Mathrani V.C., and Kenyon N.J. Systemic responses to inhaled ozone in mice: cachexia and down-regulation of liver xenobiotic metabolizing genes. Toxicol. Appl. Pharmacol. 208 (2005) 117-126
93. Leist M., Raab B., Maurer S., and Brigelius-Flohé R. Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity. Free Radical Biol. Med. 21 (1996) 297-306
94. Leon O.S., Menendez S., Merino N., Castillo R., Sam S., Perez L., Cruz E., and Bocci V. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediat. Inflamm. 7 (1998) 289-294
95. Levy J.L., Chemerynski S.M., and Sarnat J.A. Ozone exposure and mortality: an empiric bayes metaregression analysis. Epidemiology 16 (2005) 458-468
96. Li L., Hamilton Jr. R.F., and Holian A. Protection against ozone-induced pulmonary inflammation and cell death by endotoxin pretreatment in mice: role of HO-1. Inhal. Toxicol. 12 (2000) 1225-1238
97. Lippman M. Health effects of ozone, a critical review. J. Am. Air Pollut. Control Assoc. 39 (1989) 672-695
98. Long N.C., Suh J., Morrow J.D., Schiestl R.H., Murthy G.G., Brain J.D., and Frei B. Ozone causes lipid peroxidation but little antioxidant depletion in exercising and nonexercising hamsters. J. Appl. Physiol. 91 (2001) 1694-1700
99. Lubman R.L., Kim K.-J., and Crandall E.D. Alveolar epithelial barrier properties. In: Crystal R.G., et al. (Ed). The Lung. Scientific Foundation. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia 585-602
100. Martinez-Sanchez G., Al-Dalain S.M., Menendez S., Re L., Giuliani A., Candelario-Jalil E., Alvarez H., and Fernandez-Montequin J.S. Therapeutic efficacy of ozone in patients with diabetic foot. Eur. J. Pharmacol. 523 (2005) 151-161
101. Matsumoto A., Sakurai S., Shinriki N., Suzuki S., and Miura T. Therapeutic effects of ozonized olive oil in the treatment of intractable fistula and wound after surgical operation. Proceedings of the 15th ozone world congress, London. UK, 11th-15th September 2001, Medical Therapy Conference (IOA 2001, Ed) (2001), Speedprint Macmedia Ltd, Ealing, London, UK 77-84
102. Mattassi R., D'Angelo F., Bisetti P., Colombo R., and Vaghi M. Terapia con ozono per via parenterale nelle arteriopatie obliteranti periferiche: meccanismo biochimico e risultati clinici. G. Chir. VIII (1987) 109-111
103. McKinney W.J., Jaskot R.H., Richards J.H., Costa D.L., and Dreher K.L. Cytokine mediation of ozone-induced pulmonary adaptation. Am. J. Respir. Cell Mol. Biol. 18 (1998) 696-705
104. Mehlman M.A., and Borek C. Toxicity and biochemical mechanisms of ozone. Environ. Res. 42 (1987) 36-53
105. Mendiratta S., Qu Z.-C., and May J.M. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radical Biol. Med. 24 (1998) 789-797
106. Mendiratta S., Qu Z.-C., and May J.M. Enzyme-dependent ascorbate recycling in human erythrocytes: role of thioredoxin reductase. Free Radical Biol. Med. 25 (1998) 221-228
107. Menendez S., Falcon L., Simon D.R., and Landa N. Efficacy of ozonized sunflower oil in the treatment of tinea pedis. Mycoses 45 (2002) 329-332
108. Minetti M., Mallozzi C., Di Stasi A.M.M., and Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch. Biochem. Biophys. 352 (1998) 165-174
109. Molina M.J., and Rowland F.S. Stratospheric sink for chlorofluoromethanes: chlorine atom catalyzed destruction of ozone. Nature 249 (1974) 810-814
110. Montuschi P., Nightingale J.A., Kharitonov S.A., and Barnes P.J. Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Free Radical Biol. Med. 33 (2002) 1403-1408
111. Mortimer K.M., Tager I.B., Dockery D.W., Neas L., and Redline S. The effect of ozone on inner-city children with asthma: identification of susceptible subgroups. Am. J. Respir. Crit. Care Med. 162 (2000) 1838-1845
112. Mudway I.S., and Kelly F.J. Modeling the interactions of ozone with pulmonary epithelial lining fluid antioxidants. Toxicol. Appl. Pharmacol. 148 (1998) 91-100
113. Mustafa M.G. Biochemical basis of ozone toxicity. Free Radical Biol. Med. 9 (1990) 245-265
114. Nelson S.K., Bose S.K., Grunwald G.K., Myhill P., and McCord J.M. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radical Biol. Med. 40 (2006) 341-347
115. Otterbein L.E., Kolls J.K., Mantell L.L., Cook J.L., Alam J., and Choi A.M.K. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J. Clin. Invest. 103 (1999) 1047-1054
116. Olwin J.H., Ratajczak H.V., and House R.V. Successful treatment of herpetic infections by autohemotherapy. J. Altern. Complement. Med. 3 (1997) 155-158
117. Packer L., Roy S., and Sen C.K. Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv. Pharmacol. 38 (1997) 79-101
118. Pannen B.H.J., Köhler N., Hole B., Bauer M., Clemens M.G., and Geiger K.K. Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J. Clin. Invest. 102 (1998) 1220-1228
119. Parola M., Bellomo G., Robino G., Barrera G., and Dianzani M.U. 4-hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antiox. Redox Signal. 1 (1999) 255-284
120. Paulesu L., Luzzi E., and Bocci V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-a) on human leucocytes. Lymphokine Cytokine Res. 10 (1991) 409-412
121. Podda M., Traber M.G., Weber C., Yan L.-J., and Packer L. UV-irradiation depletes antioxidants and causes oxidative damage in a model of human skin. Free Radical Biol. Med. 24 (1998) 55-65
122. Poli G., and Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50 (2000) 315-321
123. Polidori M.C., Mecocci P., Levine M., and Frei B. Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. Arch. Biochem. Biophys. 423 (2004) 109-115
124. Pryor W.A. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radical Biol. Med. 17 (1994) 451-465
125. Pryor W.A., Squadrito G.L., and Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radical Biol. Med. 19 (1995) 935-941
126. Pulfer M.K., Taube C., Gelfand E., and Murphy R.C. Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J. Pharmacol. Exp. Ther. 312 (2005) 256-264
127. Rice-Evans C., and Miller N.J. Total antioxidant status in plasma and body fluids. Methods Enzymol. 234 (1994) 279-293
128. Rahman I., Clerch L.B., and Massaro D. Rat lung antioxidant enzyme induction by ozone. Am. J. Physiol. 260 (1991) L412-L418
129. Repine J.E., and Heffner J.E. Lung antioxidants. In: Crystal R.G., et al. (Ed). The Lung. Scientific Foundation. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia 2259-2269
130. Rokitansky O. Klinik und biochemie der ozonotherapie. Hospitalis 52 (1982) 643-647
131. Ruidavets J.B., Cournot M., Cassadou S., Giroux M., Meybeck M., and Ferrieres J. Ozone air pollution is associated with acute myocardial infarction. Circulation 111 (2005) 563-569
132. Samet J.M., Hatch G.E., Horstman D., Steck-Scott S., Arab L., Bromberg P.A., Levine M., McDonnell W.F., and Devlin R.B. Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am. J. Respir. Crit. Care Med. 164 (2001) 819-825
133. Sathishkumar K., Haque M., Perumal T.E., Francis J., and Uppu R.M. A major ozonation product of cholesterol, 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al, induces apoptosis in H9c2 cardiomyoblasts. FEBS Lett. 579 (2005) 6444-6450
134. Savov J.D., Whitehead G.S., Wang J., Liao G., Usuka J., Peltz G., Foster W.M., and Schwartz D.A. Ozone-induced acute pulmonary injury in inbred mouse strains. Am. J. Respir. Cell Mol. Biol. 31 (2004) 69-77
135. Schaur, R.J., 2003. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. 24, 149-159.
136. Schultze H.E., and Heremans J.F. Molecular Biology of Human Proteins vol:1 (1966), Elsevier Publishing Co., Amsterdam 1-904
137. Shinriki N., Suzuki T., Takama K., Fukunaga K., Ohgiya S., Kubota K., and Miura T. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologia 29 (1998) 229-239
138. Siems W., and Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol. Aspects Med. 24 (2003) 167-175
139. Sienra-Monge J.J., Ramirez-Aguilar M., Moreno-Macias H., Reyes-Ruiz N.I., Del Rio-Navarro B.E., Ruiz-Navarro M.X., Hatch G., Crissman K., Slade R., Devlin R.B., and Romieu I. Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone. Clin. Exp. Immunol. 138 (2004) 317-322
140. Snyder S.H., and Baranano D.E. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology 25 (2001) 294-298
141. Soulage C., Perrin D., Cottet-Emard J.M., Pequignot J., Dalmaz Y., and Pequignot J.M. Central and peripheral changes in catecholamine biosynthesis and turnover in rats after a short period of ozone exposure. Neurochem. Int. 45 (2004) 979-986
142. Spickett C.M., Jerlich A., Panasenko O.M., Arnhold J., Pitt A.R., Stelmaszynska T., and Schaur R.I. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochim. Pol. 47 (2000) 889-899
143. Stone J.R., and Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 9 (2002) 231-238
144. Strohmaier H., Hinghofer-Szalkay H., and Schaur R.J. Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J. Lipid Mediators Cell Signalling 11 (1995) 51-61
145. Tager I.B., Balmes J., Lurmann F., Ngo L., Alcorn S., and Kunzli N. Chronic exposure to ambient ozone and lung function in young adults. Epidemiology 16 (2005) 751-759
146. Takahashi Y., Takahashi S., Yoshimi T., Miura T., Mochitate K., and Kobayashi T. Increase in the mRNA levels of γ-glutamyltransferase and heme oxygenase-1 in the rat lung after ozone exposure. Biochem. Pharmacol. 53 (1997) 1061-1064
147. Tarkington B.K., Duvall T.R., and Last J.A. Ozone exposure of cultured cells and tissues. Methods Enzymol. 234 (1994) 257-265
148. Thiele J.J., Traber M.G., Tsang K., Cross C.E., and Packer L. In vivo exposure to ozone depletes vitamins C and E and induces lipid peroxidation in epidermal layers of murine skin. Free Radical Biol. Med. 23 (1997) 385-391
149. Torre-Amione G., Sestier F., Radovancevic B., and Young J. Broad modulation of tissue responses (immune activation) by Celacade may favorably influence pathologic processes associated with heart failure progression. Am. J. Cardiol. 95 suppl (2005) 30C-37C
150. Travagli, V., Zanardi, I., Bocci, V., in press. A realistic evaluation of the action of ozone on whole human blood. Int. J. Biol: Macromolecules. 38.
151. U.S. Environmental Protection Agency. EPA Green Book-8-Hour Ozone Area Standard. Available at:. http://www.epa.gov/air/oaqps/greenbk/gnsum.html Accessed August 26, 2005
152. Valacchi G., and Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediat. Inflamm. 8 (1999) 205-209
153. Valacchi G., and Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediat. Inflamm. 9 (2000) 271-276
154. Valacchi G., Weber S.U., Luu C., Cross C.E., and Packer L. Ozone potentiates vitamin E depletion by ultraviolet radiation in the murine stratum corneum. FEBS Lett. 466 (2000) 165-168
155. Valacchi G., van der Vliet A., Schock B.C., Okamoto T., Obermuller-Jevic U., Cross C.E., and Packer L. Ozone exposure activates oxidative stress responses in murine skin. Toxicology 179 (2002) 163-170
156. Valacchi G., Pagnin E., Okamoto T., Corbacho A.M., Olano E., Davis P.A., van der Vliet A., Packer L., and Cross C.E. Induction of stress proteins and MMP-9 by 0.8 ppm of ozone in murine skin. Biochem. Biophys. Res. Commun. 305 (2003) 741-746
157. Valacchi G., Pagnin E., Corbacho A.M., Olano E., Davis P.A., Packer L., and Cross C.E. In vivo ozone exposure induces antioxidant/stress-related responses in murine lungs and skin. Free Radical Biol. Med. 36 (2004) 673-681
158. Valacchi G., Fortino V., and Bocci V. The dual action of ozone on the skin. Br. J. Dermatol. 153 (2005) 1096-1100
159. Vargas M.H., Romero L., Sommer B., Zamudio P., Gustin P., and Montano L.M. Chronic exposure to ozone causes tolerance to airway hyperresponsiveness in guinea pigs: lack of SOD role. J. Appl. Physiol. 84 (1998) 1749-1755
160. Viebahn R. The Use of Ozone in Medicine (1999), ODREI Publishers, Iffezheim, Germany 1-148
161. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid. Redox Signal. 5 (2003) 493-501
162. Wang G., Umstead T.M., Phelps D.S., Al-Mondhiry H., and Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ. Health Perspect. 110 (2002) 79-84
163. Wentworth Jr. P., Nieva J., Takeuchi C., Galve R., Wentworth A.D., Dilley R.B., DeLaria G.A., Saven A., Babior B.M., Janda K.D., Eschenmoser A., and Lerner R.A. Evidence for ozone formation in human atherosclerotic arteries. Science 302 (2003) 1053-1056
164. Widdicombe J.H. Ion transport by airway epithelia. In: Crystal R.G., et al. (Ed). The Lung. Scientific Foundation. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia 573-584
165. Whitsett J.A. Pulmonary surfactant and respiratory distress syndrome in the newborn infant. In: Crystal R.G., et al. (Ed). The Lung. Scientific Foundation. 2nd ed. (1997), Lippincott-Raven Publishers, Philadelphia 2167-2177
166. Wolff H.H. Die Behandlung peripherer Durchblutungsstörungen mit Ozon. Erfahr.-Heilkd. 23 (1974) 181-184
167. Yamamoto Y. Fate of lipid hydroperoxides in blood plasma. Free Radical Res. 33 (2000) 795-800
168. Yang Y., Sharma A., Sharma R., Patrick B., Singhal S.S., Zimniak P., Awasthi S., and Awasthi Y.C. Cells preconditioned with mild transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis. J. Biol. Chem. 278 (2003) 41380-41388
169. Zhang W., He Q., Chan L.L., Zhou F., El Naghy M., Thompson E.B., and Ansari N.H. Involvement of caspases in 4-hydroxy-alkenal-induced apoptosis in human leukemic cells. Free Radical Biol. Med. 30 (2001) 699-706
170. Zhang H., Liu H., Iles K.E., Liu R.M., Postlethwait E.M., Laperche Y., and Forman H.I. 4-hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am. J. Respir. Cell Mol. Biol. 34 (2006) 174-181
171. Zuckerbraun B.S., and Billiar T.R. Heme oxygenase-1: a cellular Hercules. Hepatology 37 (2003) 742-744